Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.32 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | PDCD1LG2 | Q9BQ51 | 1/20 | 0.30 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25916946 | 0.84 | KDM4E (0.33) | KDM4EMAPK1HIF1AMTNR1AMTNR1B | |
| SCHEMBL26476788 | 0.83 | KDM4E (0.32) | KDM4EMAPK1HIF1A | |
| SCHEMBL25917043 | 0.79 | — | — | |
| SCHEMBL5415072 | 0.77 | LMNA (0.38) | — | |
| SCHEMBL14885197 | 0.76 | PAOX (0.39) | KDM4EMAPK1HIF1ATHRBPKM | |
| SCHEMBL960689 | 0.74 | KDM4E (0.56) | KDM4EMAPK1HIF1AMTNR1AMTNR1B | |
| SCHEMBL21712880 | 0.73 | MEN1 (0.47) | KDM4EMAPK1HIF1AHTT | |
| SCHEMBL25916947 | 0.72 | MTNR1A (0.30) | MTNR1AMTNR1B | |
| SCHEMBL25917045 | 0.72 | — | — | |
| SCHEMBL20781421 | 0.71 | MEN1 (0.46) | KDM4EMAPK1HIF1AHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873415-B2 | Substrate with water repellent oil repellent layer, vapor deposition material, and method for producing substrate with water repellent oil repellent layer | AGC Inc. (JP) | 2024-01-16 | — | — | US | disclosed |
| US-20230220236-A1 | COMPOSITION, SUBSTRATE WITH SURFACE LAYER, METHOD FOR PRODUCING SUBSTRATE WITH SURFACE LAYER, COMPOUNDS, AND METHODS FOR PRODUCING COMPOUNDS | AGC Inc. (JP) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230220236-A1 | COMPOSITION, SUBSTRATE WITH SURFACE LAYER, METHOD FOR PRODUCING SUBSTRATE WITH SURFACE LAYER, COMPOUNDS, AND METHODS FOR PRODUCING COMPOUNDS | ZRANB2, ITGB1, ITGB2 | KDM4E 3686/4885MAPK1 1292/4885HIF1A 3882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.